Evidence map›Paper›PMID 30305139›Full record

ArticleBreast cancer research : BCR2018

Consistent and reproducible cultures of large-scale 3D mammary epithelial structures using an accessible bioprinting platform.

John A Reid, Peter A Mollica, Robert D Bruno, Patrick C Sachs

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Review
  3. 3D bioprinting innovations: a new frontier in breast cancer research.Medical oncology (Northwood, London, England) · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Potential Use of Organoids in Regenerative Medicine.Tissue engineering and regenerative medicine · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Primary human organoids models: Current progress and key milestones.Frontiers in bioengineering and biotechnology · 2023
    Review
  17. Article
  18. Article
  19. Monitoring and modulation of the tumor microenvironment for enhanced cancer modeling.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

John A ReidBiomedical Engineering Institute, College of Engineering, Old Dominion University, 5115 Hampton Blvd, Norfolk, VA, 23529, USA.
Peter A MollicaSchool of Medical Diagnostic & Translational Sciences, College of Health Sciences, Old Dominion University, 5115 Hampton Blvd, Norfolk, VA, 23529, USA.
Robert D BrunoSchool of Medical Diagnostic & Translational Sciences, College of Health Sciences, Old Dominion University, 5115 Hampton Blvd, Norfolk, VA, 23529, USA. rbruno@odu.edu.
Patrick C SachsSchool of Medical Diagnostic & Translational Sciences, College of Health Sciences, Old Dominion University, 5115 Hampton Blvd, Norfolk, VA, 23529, USA. psachs@odu.edu.ORCID 0000-0002-0871-6789
Old Dominion University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStandard three-dimensional (3D) in vitro culture techniques, such as those used for mammary epithelial cells, rely on random distribution of cells within hydrogels. Although these systems offer advantages over traditional 2D models, limitations persist owing to the lack of control over cellular placement within the hydrogel. This results in experimental inconsistencies and random organoid morphology. Robust, high-throughput experimentation requires greater standardization of 3D epithelial culture techniques.

methodsHere, we detail the use of a 3D bioprinting platform as an investigative tool to control the 3D formation of organoids through the "self-assembly" of human mammary epithelial cells. Experimental bioprinting procedures were optimized to enable the formation of controlled arrays of individual mammary organoids. We define the distance and cell number parameters necessary to print individual organoids that do not interact between print locations as well as those required to generate large contiguous organoids connected through multiple print locations.

resultsWe demonstrate that as few as 10 cells can be used to form 3D mammary structures in a single print and that prints up to 500 μm apart can fuse to form single large structures. Using these fusion parameters, we demonstrate that both linear and non-linear (contiguous circles) can be generated with sizes of 3 mm in length/diameter. We confirm that cells from individual prints interact to form structures with a contiguous lumen. Finally, we demonstrate that organoids can be printed into human collagen hydrogels, allowing for all-human 3D culture systems.

conclusionsOur platform is adaptable to different culturing protocols and is superior to traditional random 3D culture techniques in efficiency, reproducibility, and scalability. Importantly, owing to the low-cost accessibility and computer numerical control-driven platform of our 3D bioprinter, we have the ability to disseminate our experiments with absolute precision to interested laboratories.

Indexed as

BioprintingCell Culture TechniquesCell LineEpithelial CellsFemaleHumansHydrogelsMammary Glands, HumanOrganoidsReproducibility of ResultsHydrogels3D cultureBiofabricationBioprintingMammary epitheliumOrganoidsRegenerative medicineTissue engineering

Identifiers

PMID30305139
PMCPMC6180647
OpenAlexW2896372664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.